Product Quality Issue in Chattem Inc Drugs

6 drug(s) with this reaction

591 total reports

Overview

Product Quality Issue has been reported as an adverse reaction across 6 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 591 adverse event reports mention product quality issue in connection with Chattem Inc products.

This page provides a breakdown of which Chattem Inc drugs are most commonly associated with product quality issue, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.

Chattem Inc Drugs Reporting Product Quality Issue

The following Chattem Inc drugs have product quality issue listed in their FDA adverse event reports, sorted by report count:

Other Reactions Reported for Chattem Inc Drugs

In addition to product quality issue, the following adverse reactions have been reported across Chattem Inc's drug portfolio:

DRUG INEFFECTIVEPAINNO ADVERSE EVENTFATIGUEDYSPNOEADIARRHOEAHEADACHEAPPLICATION SITE BURNPRURITUSDIZZINESSOFF LABEL USEARTHRALGIACOUGHNAUSEAAPPLICATION SITE PAINERYTHEMABACK PAINFALLRASHPAIN IN EXTREMITY

Frequently Asked Questions

Which Chattem Inc drugs cause Product Quality Issue?

6 drug(s) manufactured by Chattem Inc have product quality issue listed in their FDA adverse event reports: LIDOCAINE, MENTHOL, LIDOCAINE HCL, MENTHOL, CAMPHOR, MENTHOL, SELENIUM SULFIDE, and others.

How many Product Quality Issue reports are there for Chattem Inc drugs?

There are a combined 591 reports of product quality issue across 6 Chattem Inc drug(s) in the FDA adverse event database.

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.